Empagliflozin and Linagliptin Tablets 10/5 mg

Adult dose

The recommended starting dose of this medication is 10 mg of empagliflozin/5 mg of linagliptin once daily. If there is tolerance and additional blood sugar control is necessary, the dose can be increased to 25/5 mg once daily. Continue to administer the existing dose. This medication can be taken without regard to meals. Tablets should be swallowed whole. If a dose is missed, take it as soon as remembered, but if the next dosing time is within 12 hours, skip the missed dose and resume the regular schedule.

This medication is composed of two ingredients: empagliflozin and linagliptin, and is primarily used for blood sugar control in patients with Type 2 diabetes. This medication should not be used in certain patients. For example, individuals who are allergic to any of the ingredients or have Type 1 diabetes, diabetic ketoacidosis, or are undergoing dialysis should not take it. Patients with impaired kidney function may experience reduced effectiveness of this medication, and kidney function should be monitored regularly according to a doctor's instructions. There is limited experience in the use of this medication in patients with heart failure, so caution is required. If acute pancreatitis symptoms, such as severe abdominal pain, occur during treatment, the medication should be discontinued immediately and a doctor should be consulted. Additionally, a skin condition known as bullous pemphigoid may occur, so if there are any skin abnormalities, a doctor should be informed. Taking this medication may increase the risk of urinary tract infections and genital fungal infections, so prompt treatment is necessary if any symptoms of infection appear. Hypoglycemic symptoms may occur, so blood sugar levels should be closely monitored, especially when taken with insulin or sulfonylureas. Fluid volume loss may lead to low blood pressure, so patients undergoing hypertension treatment or elderly patients should regularly check their blood pressure and hydration status. This medication may have a mild effect on driving or operating machinery, so caution is advised, especially if there is a risk of hypoglycemia. Pregnant or breastfeeding women are advised not to take this medication and must consult a doctor if planning for pregnancy or if already pregnant. The safety and efficacy of this medication in patients under 18 years of age have not been established, so its use is not recommended in this age group. During treatment, it is important to conduct regular blood tests and physical exams to monitor for adverse reactions. In case of overdose, immediate medical attention should be sought, and measures should be taken to prevent absorption of the drug from the gastrointestinal tract. This medication should be kept out of reach of children and stored in its original container to maintain its quality.

Serious side effects

• Hives
• angioedema
• ketoacidosis
• pancreatitis
• bullous pemphigoid
• Fournier's gangrene
• perineal gangrene
• severe swelling (edema)
• heart failure
• hypoglycemia (severe hypoglycemia)

Mild side effects

• Urinary tract infections
• bacterial vaginosis
• vulvitis
• balanitis and other genital infections
• rhinitis
• cough
• constipation
• oral ulcer formation
• itching
• rashes

This medication may be sensitive to air and humidity, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the drug's effectiveness and safety over time.

Appearance

Light yellow round film-coated tablets

Package unit

30 tablets/bottle, 30 tablets/box [10 tablets/Alu-Alu*3]